Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.
about
Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring systemA modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical data.Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs.Benzodiazepines and risk of all cause mortality in adults: cohort studyCommentary: Balancing automated procedures for confounding control with background knowledgeAntidepressant use and risk for preeclampsia.Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.Change in opioid dose and change in depression in a longitudinal primary care patient cohort.Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel.Improving propensity score estimators' robustness to model misspecification using super learner.Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.Beneficiaries with cardiovascular disease and thePart D coverage gap.Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment.Association between the Part D coverage gap and adverse health outcomes.Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysisComparing Propensity Score Methods for Creating Comparable Cohorts of Chiropractic Users and Nonusers in Older, Multiply Comorbid Medicare Patients With Chronic Low Back PainPrescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing?Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemicsMatching on the disease risk score in comparative effectiveness research of new treatmentsThe Association Between Use of Chiropractic Care and Costs of Care Among Older Medicare Patients With Chronic Low Back Pain and Multiple Comorbidities.The use of clinical trials in comparative effectiveness research on mental health.Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United StatesRisk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settingsPerformance of the high-dimensional propensity score in adjusting for unmeasured confounders.A comparison of confounding adjustment methods for assessment of asthma controller medication effectivenessA review of covariate selection for non-experimental comparative effectiveness research.Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations.Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review.Control of confounding in the analysis phase - an overview for clinicians.The Potential of High-Dimensional Propensity Scores in Health Services Research: An Exemplary Study on the Quality of Care for Elective Percutaneous Coronary Interventions.Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.Comparative Effectiveness of Cancer Control and Survival after Robot-Assisted versus Open Radical Prostatectomy.Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.
P2860
Q30573765-40ECCA2C-4676-4DDF-8064-1C941C270B71Q30812957-90E872C7-1809-4E87-89C5-77A6CDD1CDA4Q31070556-BC3207FF-FAA8-4D99-99FB-8C78C3A7605CQ31161075-DC3E4232-40F3-4CA0-93CF-EAC11BAADF57Q33680604-08997DA3-64BA-4B10-8A25-E32A6276E9C0Q33877600-2E77FBB2-28A5-47FE-9F58-C2942A83925EQ33949956-1B66EE70-0995-4824-BCBC-2A86DB081386Q34158083-D67E1B6E-2053-4F59-B3A1-37EB8184CF2AQ34828788-642CE496-AD33-4BC1-B343-F6FFC0A81926Q34988126-3B780622-1ABB-410C-92EE-C2AD6220DA19Q35045666-75559C8F-3121-4442-B3F8-3199AF140CC2Q35089550-DFA7F7E0-C02B-4931-8EBE-2A1EBAC017ADQ35152699-4C9092CB-110E-4FC0-8E2D-969D136644C5Q35601849-305452FD-AD1D-4B06-9903-5849B09D2E8EQ35642254-EDA01DD0-9026-4187-B01D-A24A75B1BEAAQ35927675-CE523C90-9569-457A-B52C-412553A1190CQ35992856-8EE7FE8D-744E-4F70-9E16-4C3893235A5AQ36008497-F6C7F9AC-F1EA-4D89-96D6-2D1B974FDAEFQ36164651-79EA76D9-A241-41B2-84A8-ABF564870F55Q36337254-18216695-FA01-4517-8D9A-3E1457CF1165Q36396017-5DEDD9F8-A5EE-49F1-B797-F0952FFDF9ADQ36452126-EC7AC644-639F-48F5-814F-77DD275BF1ACQ36458864-733C6771-D154-49C6-ABB9-D04AD37DB8D3Q36488716-6A48E4B9-D5FC-42A8-AEAD-CB02B017EBB0Q36788554-2CAE23F7-4ED0-4282-A3CB-D6E6C84CDF59Q36802843-C9156C3B-F5CB-439B-8412-A73E55692D80Q36805887-04E4F084-BB8D-440D-A3C0-E2B3DFB22CF8Q37019471-C6C941F6-8196-47E6-97F1-2B977D50E147Q37109230-A415EE0E-5401-474F-97F4-88351C68B57BQ37310447-6662F692-3889-4FC4-A587-A1C87972F0E8Q37416238-CB137950-F4DE-4D89-869A-687494C2E174Q37697471-D96E5703-DB42-45C6-97A9-7E544195B27BQ38134365-C13352AD-6F18-4E0C-BC31-AF5B3613081FQ38248399-1024530B-8232-4A5E-BAF2-9B3F7BEFEC2BQ38374279-ADC9695B-E1A0-4B83-9D28-D0F68012490AQ38837483-DC7E0CB5-E9A7-4445-96C9-359C160CDD6CQ39017554-DB574149-9E6F-4A72-B038-86798DDE62F0Q39298719-2BBB6425-FAB0-4CD0-AA34-A0BA46C90267Q39308378-E73E7AE3-8FFE-44BE-B25A-1C3EB8BBD0D7Q40242247-402DC46E-03DC-43BA-84C7-68678A342BDB
P2860
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Covariate selection in high-di ...... ment effects in small samples.
@ast
Covariate selection in high-di ...... ment effects in small samples.
@en
type
label
Covariate selection in high-di ...... ment effects in small samples.
@ast
Covariate selection in high-di ...... ment effects in small samples.
@en
prefLabel
Covariate selection in high-di ...... ment effects in small samples.
@ast
Covariate selection in high-di ...... ment effects in small samples.
@en
P2093
P2860
P356
P1476
Covariate selection in high-di ...... tment effects in small samples
@en
P2093
M Alan Brookhart
Robert J Glynn
Sebastian Schneeweiss
P2860
P304
P356
10.1093/AJE/KWR001
P407
P577
2011-05-20T00:00:00Z